Beatrice Cameron
47Patents
8h-index
80Co-inventors
78Inventor score
Filing activity: Oct 28, 1994 → Mar 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6143530A | Circular DNA expression cassettes for in vivo gene transfer | Chemistry; Metallurgy | 37 | Expired |
| US8614299B2 | Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide | Chemistry; Metallurgy | 25 | Active |
| US6537793B2 | Method of separating viral particles | Physics | 21 | Expired |
| US8119770B2 | Modified soluble FGF receptor Fc fusions with improved biological activity | Chemistry; Metallurgy | 17 | Active |
| US6410273B1 | Method for producing methylated DNA | Chemistry; Metallurgy | 17 | Expired |
| US9493529B2 | Robo1-Fc fusion protein and use thereof for treating tumours | Human Necessities | 17 | Active |
| US9617345B2 | Anti-CEACAM5 antibodies and uses thereof | Physics | 15 | Active |
| US6492164B1 | Circular DNA expression cassettes for gene transfer | Chemistry; Metallurgy | 11 | Expired |
| US8852593B2 | Antagonist antibodies and their fab fragments against GPVI and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US6153597A | Pharmaceutical composition useful for nucleic acid transfection, and use thereof | Human Necessities | 7 | Expired |
| US5691163A | Cells with altered betaine catabolism and their use in producing metabolites or enzymes | Chemistry; Metallurgy | 7 | Expired |
| US6319672A | Purification of a triple helix formation with an immobilized oligonucleotide | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8647622B2 | Humanized anti-CXCR5 antibodies, derivatives thereof and their use | Chemistry; Metallurgy | 5 | Active |
| US11186649B2 | Anti-CD38 antibodies and methods of use | Chemistry; Metallurgy | 5 | Active |
| US7038026B2 | Purification of a triple heli formation with an immobilized oligonucleotide | Chemistry; Metallurgy | 4 | Expired |
| US6518062B1 | Enzyme combinations for destroying proliferative cells | Human Necessities | 4 | Expired |
| US6143518A | Method for the production of recombinant proteins, plasmids and modified cells | Chemistry; Metallurgy | 3 | Expired |
| US11530268B2 | Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infection | Chemistry; Metallurgy | 3 | Active |
| US6001631A | Topoisomerase IV, corresponding nucleotide sequences and uses thereof | Chemistry; Metallurgy | 3 | Expired |
| US11365261B2 | Anti-CD38 antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10457739B2 | Anti-CEACAM5 antibodies and uses thereof | Physics | 3 | Active |
| US6825012B2 | DNA molecules, preparation and use in gene therapy | Chemistry; Metallurgy | 2 | Expired |
| US11332542B2 | Anti-CEACAM5 antibodies and uses thereof | Physics | 1 | Active |
| US5670343A | Cloning and/or expression vectors, preparation method and their use | Chemistry; Metallurgy | 1 | Expired |
| US8017744B2 | Purification of a triple helix formation with an immobilized oligonucleotide | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.